Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 53 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 10071083

    Use of gaboxadol in the treatment of tinnitus

    OVID THERAPEUTICS INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  2. US 10071095

    1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders

    Addex Pharma, S.A. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  3. US 10071945

    Nuclear receptor modulators and their use for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  4. US 10058559

    Treatment or prevention of an intestinal disease or disorder

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  5. US 10058587

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Soricimed Biopharma Inc. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  6. US 10058556

    Method of treatment of aggression

    Supernus Pharmaceuticals, Inc. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  7. US 10052393

    Multifunctional nanomaterials for the treatment of cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  8. US 10052363

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  9. US 10052371

    Compositions and methods for treatment of cancer using bacteria

    Decoy Biosystems, Inc. · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  10. US 10046036

    Chemically modified cystathionine β-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  11. US 10046024

    Cyclic-GluR6 analogs, methods of treatment and use

    The United States of America, as represented by National Institutes of Health (NIH), U.S. Dept of Health and Human Services (DHHS), NIH Division of Extramural Inventions and Technology Resource (DEITR) · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  12. US 10039741

    Use of delta tocopherol for the treatment of lysosomal storage disorders

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  13. US 10039738

    Ulcer treatment

    UNITED ARAB EMIRATES UNIVERSITY · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  14. US 10040769

    HDAC inhibitors for the treatment of diabetic peripheral neuropathy

    Regenacy Pharmaceuticals, Inc. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  15. US 10036751

    Method of evaluating glioblastoma multiforme patient applicable to immunotherapy treatment based on dendritic cell tumor vaccines and method of prognosticating survival rate in glioblastoma mulztiforme patient after treatment

    China Medical University Hospital · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  16. US 10034863

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  17. US 10028939

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted

  18. US 10022325

    Compositions and methods for the treatment of cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  19. US 10023637

    Combination immunotherapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  20. US 10022347

    Compositions and methods for diagnosis and treatment of metabolic syndrome

    United States of America as represented by the Secretary of the Air Force · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  21. US 10016463

    Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

    United Therapeutics Corporation · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  22. US 10011589

    Treatments for gastrointestinal conditions

    The Board of Regents of the University of Texas System · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  23. US 10004782

    Glucokinase activator compositions for the treatment of diabetes

    VTV THERAPEUTICS LLC · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  24. US 10005811

    β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

    Atea Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.